|
*Print this Page
-
"What
Your Doctor May Not Tell You About Menopause" John R. Lee, MD. Warner Books, May, 1996.
-
Chakmakjian,
Z. Bioavailabliity of progesterone with different modes of adminsitration.
J Reproductive Med 32, 443, 1987.
-
Chang,
K.J. et. al. Influences of percutaneous administration of estradiol and
progesterone on human breast epithelial cell cycle in vivo. Fertility
and Sterility 63: 785-91, 1995
-
Johnson,
Blankenschtein and Langer, 1995, "Permeation of Steroids Through
Human Skin." Journal of Pharmaceutical Sciences, Vol. 84, No. 9,
Sept. 1995. Pages 1144-1146.
-
Albright,
F. 1936. Studies in ovarian function III: the menopause. Endocrinology
20:24
-
Reyes,
F.L., J.S. Winter, and C. Paiman. 1977. Pituitary ovarian relationships
preceding the menopause: a cross-sectional study of serum
follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol
and progesterone levels. American Journal of Obstetrics and
Gynecology 129:557-64
-
Prior,
J.C. 1990. Progesterone as a bone-trophic hormone. Endocr Rev
11:386-98
-
Coronary
Drug Project Research Group. 1973. Coronary drug project: findings
leading to the discontinuation of the 2.5 mg/day estrogen group. Journal
of the American Medical Association 226:652-57
-
Lipsett,
M.P. Steroid hormones, in Reproductive Endocrinology,
Physiology, and Clinical Management. Yen, S.S.C., and R.B. Jaffe, eds.
Philadelphia: W.B. Saunders Co., 1978:80
-
Hileman,
Beth. 1994. Reproductive estrogens linked to reproductive
abnormalities, cancer. Chemical and Engineering News, January
31: 19-23.
-
Weiss,
Rick. 1994. Estrogen in the environment. The Washington Post,
January 25: 10-13.
-
Raloff,
J. 1994. The gender benders. Science News 145, January 8:
24-27.
-
History
of progesterone as described by Goodman & Gilman. The Pharmacological Basis of Therapeutics.
6th edition, 1980: chapter 61 (Estrogens and Progestins: 1420), 1085-1171
-
Campbell, B.C., and P.T. Ellison. 1992. Menstrual
variation in salivary testosterone among regularly cycling women. Horm
Res 37:132-36.
-
Hargrove,
J.T., W.S. Maxson, A.C. Wentz, and L.S. Burnett. 1989. Menopausal
hormone replacement therapy with continuous daily oral micronized estradiol
and progesterone. Obstetrics & Gynecology 71:606-12
-
Stevenson,
J.C., K.F. Ganger, et al. 1990. Effects of transdermal versus oral
hormone replacement therapy on bone density in spine and proximal femur in
postmenopausal women. Lancet 336:265-26.
-
Ottoson,
U.B., B.G. Johansson, and B. von Schoultz. 1985. Subtractions of
high-density lipoprotein cholesterol during estrogen replacement therapy:
a comparison between progestogens and natural progesterone. American
Journal of Obstetrics and Gynecology 151:746-50.
-
Gambrell,
R.D. 1982. The menopause: benefits and risks of estrogen-progestogen
replacement therapy. Fertil Steril 37: 457-74.
-
Scientific
American Medicine, updated
1992. New York: Scientific American, chapter 15 (X):9.
-
Bergkvist,
L., H.O. Adami, I. Persson, R. Hoover, and C. Schairer. 1989. The
risk of breast cancer after estrogen and estrogen-progestin replacement.
New England Journal of Medicine 321:293-97.
-
Leary,
Warren E. 1995. Progesterone may play major role in the prevention of
nerve disease. New York Times, June 27, C3.
-
Braverman,
Eric. 1991. Natural estrogen and progesterone research indicates health
benefits of natural vs. Synthetic hormones. Total Health 13,
no. 5 (October): 55.
-
Prior,
J.C., Y. M. Vigna, and N. Alojado. 1991. Progesterone and the
prevention of osteoporosis, Canadian Journal of
Obstetrics/Gynecology & Women’s Health Care 3:178-84.
-
Hammond, C.B., F.R. Jelvsek, K.L. Lee, W.T. Creasman,
and R.T. Parker. 1979. Effects of long-term estrogen replacement
therapy. I. Metabolic effects. American Journal of Obstetrics and
Gynecology 133:525-36.
-
Lee,
J.R. M.D., 1990. Osteoporosis reversal: the role of progesterone. Intern
Clin Nutr Rev 10:384-91.
-
Lee,
J.R. M.D., 1990. Osteoporosis reversal with transdermal progesterone (letter).
Lancet 336:1327.
-
Lee,
J.R. M.D., 1991. Is natural progesterone the missing link in osteoporosis
prevention and treatment? Medical Hypotheses 35:316-18.
-
Lee,
John R., M.D., 1994, Slowing the Aging Process with Natural
Progesterone, BLL Publishing, California, USA, p. 12.
-
Nolan,
Charles R., M.D. et al. 1994. Aluminum and lead absorption from dietary
sources in women ingesting calcium citrate. Southern Medical
Journal. September, 87(9):894-98.
-
Lees,
B., T. Molleson, T.R. Arnett, and J.C. Stevenson. 1993. Differences in
proximal femur density over two centuries. Lancet 341:673-75.
-
Wilson, P.W.F., R. J. Garrison, and W.P. Castelli.
1985. Post-menopausal estrogen use, cigarette smoking, and
cardiovascular morbidity in women over 50. New England Journal of Medicine 313:1038-43.
-
Tribble,
D.L., and E. Frank. 1994. Dietary antioxidants, cancer, and atherosclerotic
heart disease. W J Med 161:605-12.
-
Henderson, B.E., R.K. Ross, M.C. Pike, and J.T. Casagrande.
1982. Endogenous hormones as a major factor in human cancer. Cancer
Research 42:3232-39.
|
|